Read More 1 minute read Funding News News Newleos Therapeutics Secures $93.5M Series A to Advance CNS Drug Development Key Highlights Newleos Therapeutics secures $93.5 million in Series A funding, led by Goldman Sachs Alternatives, with participation from Novo Holdings A/S,… byChris-Anne RoqueFebruary 19, 2025